Weekly Journal Scan: PREMIUM evidence that aspirin omission in STEMI patients undergoing primary percutaneous coronary intervention is unjustified and unsafe
- 27 October 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMINew England Journal of Medicine, 2026
- Intracoronary Imaging Implementation Gap in Contemporary PCIJACC: Advances, 2026
- Early Withdrawal of Aspirin after PCI in Acute Coronary SyndromesNew England Journal of Medicine, 2025
- Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial InfarctionNew England Journal of Medicine, 2025
- Factors Contributing to Low Utilization of Intracoronary Imaging in Clinical Practice: A White PaperJournal of the Society for Cardiovascular Angiography & Interventions, 2025
- Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysisThe Lancet, 2024
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal, 2023
- Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trialsEuropean Heart Journal, 2020
- Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: A 3-vessel optical coherence tomography studyAmerican Heart Journal, 2014
- Platelet Activation and AtherothrombosisNew England Journal of Medicine, 2007